OBJECTIVE
To characterize the long-term clinical and multimodal imaging (MMI) features of extensive macular atrophy with pseudodrusen (EMAP) in a U.S.
COHORT
DESIGN
Multicentre retrospective case series.
PARTICIPANTS
Patients diagnosed with EMAP between 2015 and 2025.
METHODS
Clinical records and MMI-including...
Alessandro Feo, Alberto Quarta, P. Ramtohul et al.· Canadian Journal of Ophthalm...· 1 citation
Age-related macular degeneration (AMD) is a leading cause of irreversible legal blindness worldwide. Treatments exist for late-stage AMD, but none exists for the intermediate stage (iAMD), which precedes significant vision loss. A therapy tested in iAMD would aim to prevent or slow progression to late-stage disease, me...
Alessandro Berni, P. Rosenfeld, D. Bacherini et al.· Progress in retinal and eye...· 0 citations
OBJECTIVE
To define the spatial relationship between the fovea and optic nerve head (ONH), and to evaluate their associations with foveal complications and peripapillary atrophy in posterior staphyloma.
DESIGN
Cross-sectional observational case series.
PARTICIPANTS
Eyes with pathologic myopia and posterior staphylo...
Alberto Quarta, P. Forte, Shinichiro Chujo et al.· American journal of ophthalm...· 0 citations
Macular atrophy (MA) is a major cause of long-term visual decline in neovascular age-related macular degeneration (nAMD), despite the ability of anti-vascular endothelial growth factor (anti-VEGF) therapy to control exudation. We summarize current evidence on the definition, epidemiology, risk factors, imaging features...
Xue-Nan Zhuang, Chiara Olivieri, G. Neri et al.· Survey of ophthalmology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
